Literature DB >> 16959928

Epidemiology of depression and antidepressant therapy after acute respiratory failure.

Craig Weinert1, William Meller.   

Abstract

The authors enrolled 277 subjects with acute respiratory failure to describe the epidemiology of depressive disorders and antidepressant use during and after intensive care. By SCID criteria, the prevalence of major depressive episode at 2 months was 16%, and 16% had depressive disorder not otherwise specified. Mood disorder incidence was 25% or 28%, depending on methodology. Pre-ICU physical functioning and depression were associated with 2- and 6-month depression severity. At 2 months, the prevalence of antidepressant medication use was 49%, and the incidence was 28%. Depression and antidepressant pharmacotherapy are frequent during recovery from acute respiratory failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959928     DOI: 10.1176/appi.psy.47.5.399

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  21 in total

1.  Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study.

Authors:  Oscar J Bienvenu; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Victor D Dinglas; Carl Shanholtz; Nadia Husain; Cheryl R Dennison; Margaret S Herridge; Peter J Pronovost; Dale M Needham
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

2.  Are intensive care factors associated with depressive symptoms 6 months after acute lung injury?

Authors:  David W Dowdy; Oscar Joseph Bienvenu; Victor D Dinglas; Pedro A Mendez-Tellez; Jonathan Sevransky; Carl Shanholtz; Dale M Needham
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

Review 3.  [Depressive, anxiety and posttraumatic stress disorders as long-term sequelae of intensive care treatment].

Authors:  H-P Kapfhammer
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

4.  Sleep deprivation in critical illness: its role in physical and psychological recovery.

Authors:  Biren B Kamdar; Dale M Needham; Nancy A Collop
Journal:  J Intensive Care Med       Date:  2011-01-10       Impact factor: 3.510

5.  Depressive disorders during weaning from prolonged mechanical ventilation.

Authors:  Amal Jubran; Gerald Lawm; Joanne Kelly; Lisa A Duffner; Gokay Gungor; Eileen G Collins; Dorothy M Lanuza; Leslie A Hoffman; Martin J Tobin
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

6.  Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study.

Authors:  James C Jackson; Pratik P Pandharipande; Timothy D Girard; Nathan E Brummel; Jennifer L Thompson; Christopher G Hughes; Brenda T Pun; Eduard E Vasilevskis; Alessandro Morandi; Ayumi K Shintani; Ramona O Hopkins; Gordon R Bernard; Robert S Dittus; E Wesley Ely
Journal:  Lancet Respir Med       Date:  2014-04-07       Impact factor: 30.700

7.  Depression, anxiety and alcohol abuse in a gastroenterology intensive care unit: prevalence and detection.

Authors:  Graça Cardoso; Joana Alexandre; Alda Rosa
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-07-08

8.  Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury.

Authors:  David W Dowdy; Victoriano Dinglas; Pedro A Mendez-Tellez; O Joseph Bienvenu; Jonathan Sevransky; Cheryl R Dennison; Carl Shanholtz; Dale M Needham
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

9.  Self-reported symptoms of depression and memory dysfunction in survivors of ARDS.

Authors:  Neill K J Adhikari; Mary Pat McAndrews; Catherine M Tansey; Andrea Matté; Ruxandra Pinto; Angela M Cheung; Natalia Diaz-Granados; Aiala Barr; Margaret S Herridge
Journal:  Chest       Date:  2009-03       Impact factor: 9.410

10.  Depressive symptoms and anxiety in intensive care unit (ICU) survivors after ICU discharge.

Authors:  JiYeon Choi; Judith A Tate; Mary Alana Rogers; Michael P Donahoe; Leslie A Hoffman
Journal:  Heart Lung       Date:  2016-01-12       Impact factor: 2.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.